» Articles » PMID: 25985759

An Integrative View on Sex Differences in Brain Tumors

Overview
Publisher Springer
Specialty Biology
Date 2015 May 20
PMID 25985759
Citations 101
Authors
Affiliations
Soon will be listed here.
Abstract

Sex differences in human health and disease can range from undetectable to profound. Differences in brain tumor rates and outcome are evident in males and females throughout the world and regardless of age. These observations indicate that fundamental aspects of sex determination can impact the biology of brain tumors. It is likely that optimal personalized approaches to the treatment of male and female brain tumor patients will require recognizing and understanding the ways in which the biology of their tumors can differ. It is our view that sex-specific approaches to brain tumor screening and care will be enhanced by rigorously documenting differences in brain tumor rates and outcomes in males and females, and understanding the developmental and evolutionary origins of sex differences. Here we offer such an integrative perspective on brain tumors. It is our intent to encourage the consideration of sex differences in clinical and basic scientific investigations.

Citing Articles

Sex differences in age-associated neurological diseases-A roadmap for reliable and high-yield research.

Bonkhoff A, Coughlan G, Perosa V, Alhadid K, Schirmer M, Regenhardt R Sci Adv. 2025; 11(10):eadt9243.

PMID: 40043111 PMC: 11881909. DOI: 10.1126/sciadv.adt9243.


Epidemiology and Outcome of Primary Central Nervous System Tumors Treated at King Hussein Cancer Center.

Al-Hussaini M, Al-Ani A, Amarin J, Al Sharie S, Obeidat M, Musharbash A Cancers (Basel). 2025; 17(4).

PMID: 40002185 PMC: 11852727. DOI: 10.3390/cancers17040590.


Cancers of the brain and central nervous system: global patterns and trends in incidence.

Filho A, Znaor A, Sunguc C, Zahwe M, Marcos-Gragera R, Figueroa J J Neurooncol. 2025; .

PMID: 39883354 DOI: 10.1007/s11060-025-04944-y.


Differences in tumor size, clinical, demographic, and socioeconomic profiles of central nervous system tumors among a racially diverse cohort: A retrospective case-control study.

Kim K, Lew R, Higashihara T, Yamashita S, Pang M, Stafford M Surg Neurol Int. 2025; 15():459.

PMID: 39777174 PMC: 11704430. DOI: 10.25259/SNI_190_2024.


Machine learning for predicting post-operative outcomes in meningiomas: a systematic review and meta-analysis.

Abualnaja S, Morris J, Rashid H, Cook W, Helmy A Acta Neurochir (Wien). 2024; 166(1):505.

PMID: 39688716 PMC: 11652405. DOI: 10.1007/s00701-024-06344-z.


References
1.
Cebula H, Pham T, Boyer P, Froelich S . Regression of meningiomas after discontinuation of cyproterone acetate in a transsexual patient. Acta Neurochir (Wien). 2010; 152(11):1955-6. DOI: 10.1007/s00701-010-0787-2. View

2.
Pergament E, Fiddler M, Cho N, Johnson D, Holmgren W . Sexual differentiation and preimplantation cell growth. Hum Reprod. 1994; 9(9):1730-2. DOI: 10.1093/oxfordjournals.humrep.a138783. View

3.
Van Blerkom J . Mitochondria as regulatory forces in oocytes, preimplantation embryos and stem cells. Reprod Biomed Online. 2008; 16(4):553-69. DOI: 10.1016/s1472-6483(10)60463-4. View

4.
Stark M, Clifton V, Wright I . Neonates born to mothers with preeclampsia exhibit sex-specific alterations in microvascular function. Pediatr Res. 2009; 65(3):292-5. DOI: 10.1203/pdr.0b013e318193edf1. View

5.
Ye X, Xu S, Xin Y, Yu S, Ping Y, Chen L . Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway. J Immunol. 2012; 189(1):444-53. DOI: 10.4049/jimmunol.1103248. View